Dissecting the Need for Adjuvant Therapy in Patients With Early-Stage Melanoma With Micrometastases

Free first page© 2022 by American Society of Clinical Oncology

AUTHOR'S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

Dissecting the Need for Adjuvant Therapy in Patients With Early-Stage Melanoma With Micrometastases

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Ankit Mangla

Research Funding: Nektar, TRACON Pharma

No other potential conflicts of interest were reported.

留言 (0)

沒有登入
gif